Provided by Tiger Trade Technology Pte. Ltd.

Relay Therapeutics

17.88
+0.47002.70%
Post-market: 17.880.00000.00%19:30 EDT
Volume:1.76M
Turnover:31.75M
Market Cap:3.92B
PE:-11.42
High:18.50
Open:17.01
Low:17.01
Close:17.41
52wk High:21.27
52wk Low:5.85
Shares:219.14M
Float Shares:145.00M
Volume Ratio:0.51
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5651
EPS(LYR):-1.6113
ROE:-36.77%
ROA:-22.88%
PB:4.40
PE(LYR):-11.10

Loading ...

Relay Therapeutics CFO Thomas Catinazzo Sells $329,202 in Common Shares

Reuters
·
Yesterday

X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics

THOMSON REUTERS
·
Sep 22

Relay Therapeutics CEO Sanjiv Patel Sells 48,199 Shares for $912,889.06

Reuters
·
Sep 10

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

GlobeNewswire
·
Sep 02

Major Investor Makes Dramatic Exit From Relay Therapeutics

TIPRANKS
·
Aug 29

SoftBank Vision Fund Disposes of 6,000,000 Relay Therapeutics Shares for $116.4 Million

Reuters
·
Aug 28

Relay Therapeutics Price Target Raised to $29.00/Share from $28.00 by HC Wainwright & Co.

Dow Jones
·
Aug 20

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Reuters
·
Aug 20

Relay Therapeutics (RLAY) Stock May Be Fully Valued After A 7x Run

Simply Wall St.
·
Aug 20

Relay Therapeutics CFO Thomas Catinazzo Disposes of 17,717 Common Shares Worth $349,703.58

Reuters
·
Aug 19

Relay Therapeutics price target raised to $31 from $28 at JPMorgan

TIPRANKS
·
Aug 16

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Relay Therapeutics (RLAY)

TIPRANKS
·
Aug 14

Relay Therapeutics Price Target Raised to $26.00/Share from $21.00 by Citizens

Dow Jones
·
Aug 10

Relay Therapeutics price target raised to $26 from $21 at Citizens

TIPRANKS
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Relay Therapeutics (RLAY) and Amylyx Pharmaceuticals Inc (AMLX)

TIPRANKS
·
Aug 10

Relay Therapeutics is Maintained at Overweight by Barclays

Dow Jones
·
Aug 08

CytomX Q2 Revenue Misses, Partly Hurt by Lower Research Activities in the Astellas Collaboration

Reuters
·
Aug 07

Relay Therapeutics Q2 2026 earnings: Clinical spending rises with cash runway into 2029

TradingKey
·
Aug 07

Relay Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Earnings Flash (RLAY) Relay Therapeutics Posts Q2 Loss $0.41 per Share, vs. FactSet Est of $0.39 Loss

MT Newswires Live
·
Aug 07